SI-BONE, Inc. (SIBN) Financial Statements
Industry: Surgical & Medical Instruments & Apparatus
In fiscal 2025, SI-BONE reported revenue of $200.9M, up 20.2% from $167.2M the year before. Net income was -$18.9M (a -9.4% net margin), or -$0.44 per diluted share. Gross margin was 79.6% and operating margin was -11.1%. Operating activities generated -$675,000 of cash, leaving -$9.1M of free cash flow. At fiscal year end, SI-BONE held $238.6M in total assets against $61.0M in total liabilities, including $42.2M of cash and equivalents.
Open the full interactive SI-BONE financials → Quarterly statements, key ratios, valuation history and price charts.
SI-BONE Key Stats
| Share Price | $19.68 |
|---|---|
| Market Cap | $875.3M |
| Revenue YoY Growth | +20.2% |
| 52-Week Range | $11.61 – $21.40 |
| Shares Outstanding | 44.5 million (basic, 2026 Q2) |
SI-BONE Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $73.4M | $90.2M | $106.4M | $138.9M | $167.2M | $200.9M |
| Cost of Goods Sold | $8.9M | $10.4M | $15.7M | $29.5M | $35.1M | $41.0M |
| Gross Profit | $64.5M | $79.7M | $90.7M | $109.4M | $132.1M | $159.9M |
| Operating Income | -$38.6M | -$51.7M | -$59.6M | -$46.9M | -$35.2M | -$22.3M |
| Pre-Tax Income | -$43.7M | -$56.6M | -$61.3M | -$43.3M | -$30.9M | -$18.9M |
| Income Tax | — | — | $0 | $0 | $0 | $0 |
| Net Income | -$43.7M | -$56.6M | -$61.3M | -$43.3M | -$30.9M | -$18.9M |
| Diluted EPS | -$1.50 | -$1.71 | -$1.79 | -$1.13 | -$0.75 | -$0.44 |
SI-BONE Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $48.7M | $56.3M | $52.6M | $56.0M |
| Net Income | -$4.6M | -$1.6M | -$4.3M | -$4.1M |
| Diluted EPS | -$0.11 | -$0.04 | -$0.10 | -$0.09 |
SI-BONE Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $53.6M | $63.4M | $20.7M | $33.3M | $34.9M | $42.2M |
| Current Assets | $218.2M | $175.9M | $137.6M | $211.4M | $207.8M | $216.1M |
| Total Assets | $223.1M | $190.5M | $157.6M | $230.4M | $230.4M | $238.6M |
| Current Liabilities | $13.5M | $16.9M | $21.2M | $23.5M | $27.1M | $25.3M |
| Total Long-Term Debt | $39.5M | $35.0M | $35.2M | $36.1M | $35.5M | $35.6M |
| Total Liabilities | $53.8M | $56.1M | $59.2M | $61.0M | $63.5M | $61.0M |
| Shareholders' Equity | $169.4M | $134.4M | $98.3M | $169.4M | $167.0M | $177.5M |
SI-BONE Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$30.7M | -$39.5M | -$41.7M | -$18.7M | -$12.4M | -$675,000 |
| Cash From Investing | -$62.9M | $51.6M | -$2.8M | -$59.8M | $12.6M | $4.2M |
| Cash From Financing | $136.4M | -$1.7M | $2.2M | $90.9M | $2.0M | $3.4M |
| Free Cash Flow | -$33.2M | -$45.9M | -$51.2M | -$26.5M | -$22.9M | -$9.1M |
Figures from SI-BONE's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full SI-BONE financials page for every line item.
SI-BONE Company Profile
| Ticker | SIBN |
|---|---|
| Exchange | Nasdaq |
| Industry | Surgical & Medical Instruments & Apparatus |
| Headquarters | Santa Clara, California |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0001459839 |
Frequently Asked Questions
What was SI-BONE's revenue in fiscal 2025?
SI-BONE (SIBN) reported revenue of $200.9M for fiscal 2025.
What is SI-BONE's annual revenue history?
SI-BONE's annual revenue by fiscal year: 2020: $73.4M; 2021: $90.2M; 2022: $106.4M; 2023: $138.9M; 2024: $167.2M; 2025: $200.9M.
What was SI-BONE's net income in fiscal 2025?
SI-BONE reported net income of -$18.9M for fiscal 2025.
What was SI-BONE's earnings per share (EPS) in fiscal 2025?
SI-BONE's diluted EPS was -$0.44 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did SI-BONE generate in fiscal 2025?
SI-BONE generated -$9.1M of free cash flow in fiscal 2025.
What was SI-BONE's revenue last quarter?
In its most recent reported quarter (2026 Q2), SI-BONE reported revenue of $56.0M.
How much debt does SI-BONE have?
SI-BONE reported $35.6M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of SI-BONE are outstanding?
SI-BONE reported a weighted average of 44.5 million basic shares outstanding in 2026 Q2.
What is SI-BONE's market cap?
Based on its latest closing price, SI-BONE (SIBN) has a market capitalization of about $875.3M.
When does SI-BONE's fiscal year end?
SI-BONE's fiscal year end, as registered with the SEC, is December 31.
Where is SI-BONE headquartered?
SI-BONE lists its business address in Santa Clara, California in its SEC filings.
SI-BONE Competitors & Similar Companies
See all 109 Surgical & Medical Instruments & Apparatus companies →